SCHEMBL4652633

SCHEMBL4652633

C=CCc1ccc(OC(=O)c2ccccc2O)c(OC)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.71
KMT2A Q03164 3/20 0.71
CYP3A4 P08684 2/20 0.71
TDP1 Q9NUW8 1/20 0.71
L3MBTL1 Q9Y468 1/20 0.71
PTGS1 P23219 2/20 0.66
ALDH1A1 P00352 3/20 0.58
PPARA Q07869 3/20 0.58
PPARG P37231 1/20 0.58
PPARD Q03181 1/20 0.58
ALOX5 P09917 1/20 0.58
AR P10275 1/20 0.58
TRPM8 Q7Z2W7 1/20 0.58
MAOA P21397 1/20 0.57
MAOB P27338 1/20 0.57
PRSS1 P07477 1/20 0.56
ACR P10323 1/20 0.56
GABRA1 P14867 1/20 0.53
GABRB2 P47870 1/20 0.53
NPC1 O15118 3/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL526114 0.87 TDP1 (0.52) MEN1KMT2ACYP3A4TDP1L3MBTL1
Eugenol SCHEMBL14167717 0.86 PTGS1 (0.68) MEN1KMT2ACYP3A4TDP1L3MBTL1
SCHEMBL20723732 0.86 MEN1 (0.70) MEN1KMT2ACYP3A4TDP1L3MBTL1
Benzyl Salicylate SCHEMBL11345114 0.86 KMT2A (0.60) MEN1KMT2ACYP3A4TDP1L3MBTL1
Eugenyl Benzoat SCHEMBL31089296 0.83 MEN1 (1.00) MEN1KMT2ACYP3A4TDP1L3MBTL1
Eugenyl Benzoat SCHEMBL357066 0.83 MEN1 (1.00) MEN1KMT2ACYP3A4TDP1L3MBTL1
SCHEMBL20213687 0.83 MEN1 (0.76) MEN1KMT2ACYP3A4TDP1L3MBTL1
Eugenol SCHEMBL4652636 0.82 ALDH1A1 (0.70) MEN1KMT2ACYP3A4TDP1L3MBTL1
SCHEMBL2818564 0.82 SMN1; SMN2 (0.49) MEN1KMT2ACYP3A4TDP1L3MBTL1
Methyleugenol SCHEMBL26688181 0.81 ALDH1A1 (0.73) MEN1KMT2ACYP3A4TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3689849-B1 PERFUME PRECURSOR TAKASAGO PERFUMERY CO LTD (JP) 2025-01-15 EP claimed
US-4513052-A LEUCO DYE, FLUORAN DYE AND A PHENOLIC COMPOUND RICOH CO., LTD. (JP) 1985-04-23 US claimed
JP-9249549-A None JP disclosed
JP-9241116-A None JP disclosed
JP-6287135-A None JP disclosed
EP-3689849-B1 PERFUME PRECURSOR TAKASAGO PERFUMERY CO LTD (JP) 2025-01-15 EP disclosed
US-11802258-B2 Perfume precursor TAKASAGO INTERNATIONAL CORPORATION (JP) 2023-10-31 US disclosed
US-20210214644-A1 PERFUME PRECURSOR TAKASAGO INTERNATIONAL CORPORATION (JP) 2021-07-15 US disclosed
EP-3689849-A1 PERFUME PRECURSOR Takasago International Corporation (JP) 2020-08-05 EP disclosed
CN-111108090-A Fragrance precursor 高砂香料工业株式会社 2020-05-05 CN disclosed
EP-1602354-B1 Use of polyglutamic acid or its salts MEIJI SEIKA KAISHA (JP) 2008-11-05 EP disclosed
US-6162459-A Acyclovir transdermal delivery system NATIONAL SCIENCE COUNCIL (TW) 2000-12-19 US disclosed
US-6117562-A A THERMAL IMAGE TRANSFER INK LAYER FORMED ON THE SUPPORT; INK LAYER COMPRISING A COLORING AGENT, A RESIN AND A PLASTICIZER FOR LOWERING THE MELT VISCOSITY OF RESIN RICOH COMPANY, LTD. (JP) 2000-09-12 US disclosed
US-5716477-A CONSISTS OF A SUPPORT AND THERMAL IMAGE TRANSFER INK LAYER FORMED ON SAID SUPPORT CONSISTS OF A COLORING AGENT AND A PLASTICIZER FOR LOWERING MELT VISCOSITY OF THE RESIN, HIGH THERMOSENSITIVITY ON CLOTH, PLASTIC, OR PAPER RECEIVER RICOH COMPANY, LTD. (JP) 1998-02-10 US disclosed
JP-H09249549-A COSMETIC COMPOSITION LION CORP 1997-09-22 JP disclosed
JP-H09241116-A COSMETIC COMPOSITION LION CORP 1997-09-16 JP disclosed
CN-1129573-A Antiviral Drug Acyclovir Percutaneous Absorption Preparation HU YOUPU (CN) 1996-08-28 CN disclosed
JP-H06287135-A EXTERNAL AGENT COMPOSITION FOR SKIN LION CORP 1994-10-11 JP disclosed
US-4562448-A Heat-sensitive transfer medium RICOH CO., LTD. (JP) 1985-12-31 US disclosed
US-4513052-A LEUCO DYE, FLUORAN DYE AND A PHENOLIC COMPOUND RICOH CO., LTD. (JP) 1985-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11802258-B2 Perfume precursor CYP2E1, ADH1A, CYP1A1 MEN1 2737/4885KMT2A 2414/4885CYP3A4 73/4885
US-20210214644-A1 PERFUME PRECURSOR CYP2E1, ADH1A, CYP1A1 MEN1 2737/4885KMT2A 2414/4885CYP3A4 73/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.